Cargando…
Resveratrol ameliorates liver fibrosis induced by nonpathogenic Staphylococcus in BALB/c mice through inhibiting its growth
BACKGROUND: The altered gut microbiota is implicated in the pathogenesis of liver fibrosis. Resveratrol is a candidate for the treatment of liver fibrosis, which could ameliorate the dysregulation of gut microbiota in mice. This study aimed to clarify the role and mechanism of resveratrol in gut mic...
Autores principales: | Li, Zhiqin, Dong, Jianxia, Wang, Meng, Yan, Jingya, Hu, Yushu, Liu, Yang, Pan, Yajie, Li, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066969/ https://www.ncbi.nlm.nih.gov/pubmed/35508992 http://dx.doi.org/10.1186/s10020-022-00463-y |
Ejemplares similares
-
Resveratrol ameliorates iron overload induced liver fibrosis in mice by regulating iron homeostasis
por: Wang, Hua, et al.
Publicado: (2022) -
Nonpathogenic Cutibacterium acnes Confers Host Resistance against Staphylococcus aureus
por: Tsuru, Ayano, et al.
Publicado: (2021) -
Charting the Lipopeptidome of Nonpathogenic Pseudomonas
por: Cesa-Luna, Catherine, et al.
Publicado: (2023) -
Comparative evaluation of nephroprotective potential of resveratrol and piperine on nephrotic BALB/c mice
por: Kakalij, Rahul Motiram, et al.
Publicado: (2016) -
Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice
por: Wu, Han, et al.
Publicado: (2016)